Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 022161

0.4MG/5ML (0.08MG/ML)
Marketing Status: Prescription
Active Ingredient: REGADENOSON
Proprietary Name: LEXISCAN
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 0.4MG/5ML (0.08MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N022161
Product Number: 001
Approval Date: Apr 10, 2008
Applicant Holder Full Name: ASTELLAS PHARMA US INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English